---
title: "12 Health Care Stocks Moving In Wednesday's Pre-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284569253.md"
description: "In Wednesday's pre-market session, KalVista Pharmaceuticals saw a significant gain of 38.5%, reaching $26.66, with a market cap of $985.5 million. Other notable gainers included GlucoTrack (+26.64%), Akanda (+16.52%), and NeoGenomics (+14.19%). Conversely, BiomX experienced the largest decline, falling 18.6% to $0.7. Other losers included CollPlant Biotechnologies (-12.95%) and China Pharma Holding (-11.35%). The Q1 earnings report was released today, impacting stock movements."
datetime: "2026-04-29T12:06:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284569253.md)
  - [en](https://longbridge.com/en/news/284569253.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284569253.md)
---

# 12 Health Care Stocks Moving In Wednesday's Pre-Market Session

### Gainers

-   **KalVista Pharmaceuticals** (NASDAQ:KALV) shares rose 38.5% to $26.66 during Wednesday's pre-market session. The company's market cap stands at $985.5 million.
-   **GlucoTrack** (NASDAQ:GCTK) stock increased by 26.64% to $1.06.
-   **Akanda** (NASDAQ:AKAN) stock increased by 16.52% to $20.38. The market value of their outstanding shares is at $9.3 million.
-   **NeoGenomics** (NASDAQ:NEO) shares increased by 14.19% to $10.3. The market value of their outstanding shares is at $1.1 billion. The company's, Q1 earnings came out yesterday.
-   **Icon** (NASDAQ:ICLR) shares rose 14.15% to $117.0. The company's market cap stands at $7.8 billion.
-   **Traws Pharma** (NASDAQ:TRAW) stock rose 12.39% to $1.36. The market value of their outstanding shares is at $12.2 million.

### Losers

-   **BiomX** (AMEX:PHGE) shares fell 18.6% to $0.7 during Wednesday's pre-market session. The market value of their outstanding shares is at $7.5 million.
-   **CollPlant Biotechnologies** (NASDAQ:CLGN) shares declined by 12.95% to $0.34. The company's market cap stands at $4.9 million.
-   **China Pharma Holding** (AMEX:CPHI) shares fell 11.35% to $0.5. The company's market cap stands at $2.8 million.
-   **GE HealthCare Techs** (NASDAQ:GEHC) shares fell 10.26% to $61.48. The market value of their outstanding shares is at $31.2 billion. As per the news, the Q1 earnings report came out today.
-   **Intellia Therapeutics** (NASDAQ:NTLA) stock decreased by 9.1% to $12.0. The company's market cap stands at $1.5 billion.
-   **Onconetix** (NASDAQ:ONCO) shares declined by 8.99% to $0.7. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [GCTK.US](https://longbridge.com/en/quote/GCTK.US.md)
- [NEO.US](https://longbridge.com/en/quote/NEO.US.md)
- [KALV.US](https://longbridge.com/en/quote/KALV.US.md)
- [AKAN.US](https://longbridge.com/en/quote/AKAN.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [ICLR.US](https://longbridge.com/en/quote/ICLR.US.md)
- [TRAW.US](https://longbridge.com/en/quote/TRAW.US.md)
- [PHGE.US](https://longbridge.com/en/quote/PHGE.US.md)
- [CLGN.US](https://longbridge.com/en/quote/CLGN.US.md)
- [CPHI.US](https://longbridge.com/en/quote/CPHI.US.md)
- [GEHC.US](https://longbridge.com/en/quote/GEHC.US.md)
- [NTLA.US](https://longbridge.com/en/quote/NTLA.US.md)
- [ONCO.US](https://longbridge.com/en/quote/ONCO.US.md)

## Related News & Research

- [Merger Agreement With Chiesi Puts Strategic Handcuffs on KalVista, Raising Execution and Liquidity Risks](https://longbridge.com/en/news/286635514.md)
- [Roth MKM Sticks to Their Buy Rating for Capricor Therapeutics (CAPR)](https://longbridge.com/en/news/286497683.md)
- [Full Transcript: DRI HEALTHCARE TRUST Q1 2026 Earnings Call](https://longbridge.com/en/news/286578500.md)
- [BUZZ-Street View: Regeneron's melanoma trial setback raises bigger-picture questions](https://longbridge.com/en/news/286769076.md)
- [Leerink Partners Sticks to Their Buy Rating for Ibio (IBIO)](https://longbridge.com/en/news/286588262.md)